2022 annual financial data
Harmony Biosciences Holdings 2022 Operating income growth
Direct answer
Operating income growth was 37.31%.
Operating income was 120,186,000 USD and net income was 181,468,000 USD.
Operating cash flow was 144,466,000 USD.
Get free Harmony Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 437,855,000 USD
- Operating income
- 120,186,000 USD
- Net income
- 181,468,000 USD
- Operating cash flow
- 144,466,000 USD